ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Shire plc 

725 Chesterbrook Boulevard

Wayne  Pennsylvania  19087-5637  U.S.A.
Phone: 484-595-8800 Fax: 484-595-8200


SEARCH JOBS

Founded in 1986, Shire is a fast-growing company with more than 5,300 employees all fully focused on a single purpose: to enable people with life-altering conditions to lead better lives. Our Brave culture encourages a challenge to the status quo, collaboration across cultures and geographic boundaries, the pursuit of innovation, and a firm focus on responsibility in everything we do.

Shire’s operations are structured across three businesses – Human Genetic Therapies, Regenerative Medicine, and Specialty Pharmaceuticals – with a major US presence in Massachusetts, California and Pennsylvania respectively; and international hub offices in the United Kingdom, Switzerland and Brazil.

We are always looking for talented, team-oriented individuals who are motivated by the ability to make an immediate and sustained contribution in the workplace, as well as opportunities for professional development and growth.

To learn more about Shire, visit www.shire.com. For more information on career opportunities with Shire, please visit: www.timetobebrave.com.

Shire



 Key Statistics


Email:
Ownership: Public

Web Site: Shire plc
Employees:
Symbol: SHPG
 









 Company News
Shire plc (SHPG) to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5/17/2013 8:36:50 AM    More...
Nimbus Discovery Announces Agreement With Shire plc (SHPG) to Co-Develop Therapies for Rare Diseases 5/8/2013 10:58:44 AM    More...
Shire plc (SHPG) Release: New Chief Executive Reports Q1 Results and Sets out Strategy for Growth 5/2/2013 7:22:45 AM    More...
FDA Approves Shire plc (SHPG)'s Vyvanse for Children With ADHD 5/2/2013 6:59:48 AM    More...
Shire plc (SHPG) Settles With Actavis, Watson Pharmaceuticals, Inc. (WPI) on ADHD Drug 4/25/2013 8:37:24 AM    More...
Shire plc (SHPG) Release: Dermagraft® Now Available in Canada for the Treatment of Diabetic Foot Ulcers 3/25/2013 10:22:45 AM    More...
Shire plc (SHPG) Boosts Eye Business With $160 Million SARcode Buy 3/25/2013 6:45:16 AM    More...
Shire plc (SHPG) Boosts Rare Diseases Business by Buying Premacure 3/12/2013 7:26:31 AM    More...
Shire plc (SHPG)'s New Chief Said to Eye Two to Three Acquisitions 2/20/2013 11:38:52 AM    More...
Shire plc (SHPG)'s VPRIV® Wins First Ever "Novel Treatment Award" From Lysosomal Disease Network at Their 9th WORLD Symposium 2/19/2013 10:57:27 AM    More...
123